Valeant Pharma (VRX) on Watch Ahead of Citron Left Interview
Bouncing 8% in early trade after Citron Research dialed back on the explosiveness of its report, Valeant ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
